What is Nospa drug use for?
It is used to reduce smooth muscle spasms in the following cases: o Cholelithiasis, inflammation of the gallbladder (cholecystitis), inflammation of the biliary tract (cholangitis and papilitis); o Kidney stones (nephrolithiasis), ureteral stones (ureteroliasis), inflammation of the renal calyx, inflammation of the …
When should Nospa be taken?
Usual dose Adults: orally 3–6 tablets in a day, divided between 2–3 doses. Do not exceed the recommended dose. If symptoms do not improve, talk to your doctor. Check with your doctor or pharmacist if you are not sure.
What is Forte in tablets?
Forte-SP Tablet is a pain-relieving medicine. It helps in relieving moderate pain and reducing fever. It is used in various conditions such as muscle ache, back pain, joint pain, menstrual cramps, and toothache.
Can you overdose on No-Spa?
If you take more No-Spa than you should Based on the data available in published literature and based on reports of side effects, an overdose of drotaverine may cause weakness, malaise, dizziness, vomiting, headache, a drop in blood pressure and sleepiness.
What does your forte mean?
: something in which a person shows special ability Music is my forte.
What is the difference between Neurobion and Neurobion Forte?
Neurobion contains Methylcobalamin, Pyridoxine, and Nicotinamide. It is prescribed for treating vitamin B deficiency. It is used for mild B vitamin deficiencies. Neurobion forte is a red-coloured, more potent version that is now in use.
What causes a lot of gas in your stomach?
Excess upper intestinal gas can result from swallowing more than a usual amount of air, overeating, smoking or chewing gum. Excess lower intestinal gas can be caused by eating too much of certain foods, by the inability to fully digest certain foods or by a disruption in the bacteria normally found in the colon.
What is the generic name for No-Spa?
|Trade names||No-Spa, Doverin|
|AHFS/Drugs.com||International Drug Names|
|Routes of administration||Oral, intravenous, intramuscular|
|ATC code||A03AD02 (WHO)|